Sens-it-iv: Bioinformatic Simulation to Evaluate Potential Allergens
Filed in archive Diagnostics, Methodologies and Instrumentation , Genomics, Proteomics and Bioinformatics on February 7, 2006

This entry is submitted by Gloria Gamat, via Creative Reporter.The most reliable way of testing the allergenic potential of a chemical substance is through animal experimentation. However, the European Union wishes to gradually reduce the number of animals used in toxicity tests.
Sens-it-iv, an integrated European research project aims to develop alternative methods to animal testing in the area of allergy:
The ULP dermatochemistry laboratory, directed by Professor Jean-Pierre Lepoittevin, is the only chemistry laboratory taking part in the Sens-it-iv project. Its role (dedicated mostly to organic chemistry) will be to evaluate the chemical reactivity of different molecules and to study the reaction mechanisms between allergens (foreign substances capable of triggering an allergic reaction in the body) and cutaneous biomolecules (skin proteins).
The results from each partnering laboratory will be gathered and pooled together in order to determine the structure and action of each chemical substance using the technique of bioinformatic simulation to ascertain their toxicity without using the animal experimentation model.
Source: Innovations ReportAbout Gloria Gamat: Gloria is a proud single-mom to Raine (Rainier Brando: born 29 December 2002) and a Chemist. Gloria also blogs about motherhood at EMothersOnline and about life and travel in the Philippines at The Philippine Culture Blog and at Pinoy Travel Blog respectively.

Tags: allergy bioinformatics biotech simulation potential bioinformatic+simulation sens+bioinformatic eval
Vote for Sens-it-iv: Bioinformatic Simulation to Evaluate Potential Allergens:
|
Rating: 9.00 out of 2 vote(s) cast.
|
Most Popular
Best of
Biotech Hubs and Facilities
Biotech/Science Blogs
Corporate and Industrial News
Diagnostics, Methodologies and Instrumentation
Did you know
Drugs, Vaccines and Therapeutics
Energy, Environment and Ecology
Food and Agriculture
Gene Therapy
Genomics, Proteomics and Bioinformatics
Information About
Meetings and Other Events
Microbiology
Misc
Nanomedicine
Other Biotechnology News
Patents and Intellectual Property Rights
Quick introduction
Stem Cells
